FGP
ACH

Freestone Grove Partners’s Accendra Health ACH Stock Holding History

Freestone Grove Partners’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-541,967
Closed -$4.89M – 807
2025
Q1 		$4.89M Buy
541,967
+149,852
+38% +$1.58M 0.05% 283
2024
Q4 		$5.12M Buy
+392,115
New +$5.23M 0.06% 235

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Freestone Grove Partners's ACH Position: Q2 2025 in Review

Freestone Grove Partners sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 541,967 shares — an estimated $4.89M sold.

Freestone Grove Partners first reported a position in ACH in Q4 2024 and held it in 2 quarters. The position peaked at $5.12M in Q4 2024. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

  • Freestone Grove Partners reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 541,967 Accendra Health shares in Q2 2025, an estimated $4.89M.
  • Freestone Grove Partners first reported a position in Accendra Health in Q4 2024 and held it in 2 quarters.
  • Freestone Grove Partners's Accendra Health position peaked at $5.12M in Q4 2024.
  • 234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on Freestone Grove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.